Lamoste, Roscia .

HRN: 25-22-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2024
CEFUROXIME 500MG (TAB)
09/17/2024
09/24/2024
PO
500mg Tab
BID
UTI
Waiting Final Action 
09/19/2024
CEFUROXIME 1.5GM (VIAL)
09/19/2024
09/20/2024
IV
1.5gm
Q8 X 4 Doses
Post OP Prophylaxis
Waiting Final Action 
09/19/2024
CEFUROXIME 500MG (TAB)
09/20/2024
09/27/2024
PO
500mg Tab
BID
Post OP Prophylaxis
Waiting Final Action 
09/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/19/2024
09/20/2024
IV
500mg
Q8 X 4 Doses
Post OP Prophylaxis
Waiting Final Action 
09/19/2024
METRONIDAZOLE 500MG (TAB)
09/20/2024
09/27/2024
PO
500mg
Q8
Post OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: